<html>
<head>
<title>Utah Legislature HB0236</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CHARITABLE PRESCRIPTION DRUG RECYCLING</b></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><center>PROGRAM</b></font><font face="Arial" size="2"></center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2016 GENERAL SESSION</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Gage Froerer</b></font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill creates a program that allows certain pharmacies to accept and dispense<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;donated unused prescription medications to certain individuals.<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends the Pharmacy Practice Act;<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;defines terms;<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;directs the Division of Occupational and Professional Licensing (DOPL) to make<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rules, in consultation with the Utah State Board of Pharmacy, to create a charitable<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescription drug recycling program;<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establishes criteria for prescription drugs eligible for the program;<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establishes requirements for donors and pharmacies;<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;limits the liability of program participants;<br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;directs DOPL to make rules establishing certain requirements, standards,<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;procedures, and processes; and<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical changes.<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-502">58-17b-502</a></b>, as last amended by Laws of Utah 2015, Chapter 336<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-503">58-17b-503</a></b>, as last amended by Laws of Utah 2011, Chapter 366<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-901">58-17b-901</a></b>, Utah Code Annotated 1953<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-902">58-17b-902</a></b>, Utah Code Annotated 1953<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-903">58-17b-903</a></b>, Utah Code Annotated 1953<br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-904">58-17b-904</a></b>, Utah Code Annotated 1953<br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-905">58-17b-905</a></b>, Utah Code Annotated 1953<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-906">58-17b-906</a></b>, Utah Code Annotated 1953<br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-907">58-17b-907</a></b>, Utah Code Annotated 1953<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>58-17b-502</b><a name="58-17b-502"></a> is amended to read:<br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-17b-502.</b>   <b>Unprofessional conduct.</b><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Unprofessional conduct" includes:<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  willfully deceiving or attempting to deceive the division, the board, or their agents<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as to any relevant matter regarding compliance under this chapter;<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) (a)  except as provided in Subsection (2)(b):<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  paying or offering rebates to practitioners or any other health care providers, or<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receiving or soliciting rebates from practitioners or any other health care provider; or<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  paying, offering, receiving, or soliciting compensation in the form of a commission,<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;bonus, rebate, kickback, or split fee arrangement with practitioners or any other health care<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider, for the purpose of obtaining referrals.<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  Subsection (2)(a) does not apply to:<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  giving or receiving price discounts based on purchase volume;<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  passing along pharmaceutical manufacturer's rebates; or<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  providing compensation for services to a veterinarian.<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  misbranding or adulteration of any drug or device or the sale, distribution, or<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensing of any outdated, misbranded, or adulterated drug or device;<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)  engaging in the sale or purchase of drugs or devices that are samples or packages<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;bearing the inscription "sample" or "not for resale" or similar words or phrases;<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)  except as provided in Section <a href="#58-17b-503">58-17b-503</a> <u>or Part 9, Charitable Prescription Drug</u><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Recycling Act</u>, accepting back and redistributing [<strike>of</strike>] any unused drug, or a part of it, after it<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;has left the premises of any pharmacy, unless the drug is in a unit pack, as defined in Section<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-503">58-17b-503</a>, or the manufacturer's sealed container, as defined in rule;<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)  an act in violation of this chapter committed by a person for any form of<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;compensation if the act is incidental to the person's professional activities, including the<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;activities of a pharmacist, pharmacy intern, or pharmacy technician;<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)  violating Federal Title II, P.L. 91, Controlled Substances Act, Title 58, Chapter 37,<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Utah Controlled Substances Act, or rules or regulations adopted under either act;<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)  requiring or permitting pharmacy interns or technicians to engage in activities<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;outside the scope of practice for their respective license classifications, as defined in this<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chapter and division rules made in collaboration with the board, or beyond their scope of<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;training and ability;<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)  administering:<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  without appropriate training, as defined by rule;<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  without a physician's order, when one is required by law; and<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  in conflict with a practitioner's written guidelines or written protocol for<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administering;<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)  disclosing confidential patient information in violation of the provisions of the<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Health Insurance Portability and Accountability Act of 1996 or other applicable law;<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)  engaging in the practice of pharmacy without a licensed pharmacist designated as<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the pharmacist-in-charge;<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)  failing to report to the division any adverse action taken by another licensing<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jurisdiction, government agency, law enforcement agency, or court for conduct that in<br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance would be considered unprofessional conduct under this section; and<br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)  as a pharmacist or pharmacy intern, compounding a prescription drug in a dosage<br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;form which is regularly and commonly available from a manufacturer in quantities and<br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;strengths prescribed by a practitioner.<br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>58-17b-503</b><a name="58-17b-503"></a> is amended to read:<br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-17b-503.</b>   <b>Exception to unprofessional conduct.</b><br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  For purposes of this section:<br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  "Licensed intermediate care facility for people with an intellectual disability" means<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an intermediate care facility for people with an intellectual disability that is licensed as a<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nursing care facility or a small health care facility under Title 26, Chapter 21, Health Care<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Facility Licensing and Inspection Act.<br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  "Nursing care facility" [<strike>has the same definition as</strike>] <u>means the same as that term is</u><br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>defined</u> in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-21-2&session=2016GS">26-21-2</a>.<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  "Unit pack" means a tamper-resistant nonreusable single-dose single-drug package<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with identification that indicates the lot number and expiration date for the drug.<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  [<strike>Notwithstanding the provisions of Subsection <a href="#58-17b-502">58-17b-502</a>(5), a</strike>] <u>A</u> pharmacist<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;may<u>:</u><br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  accept and redistribute an unused drug under Part 9, Charitable Prescription Drug</u><br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Recycling Act; or</u><br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)</u>  accept back and redistribute any unused drug, or a part of it, after it has left the<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;premises of the pharmacy if:<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(a)</strike>] <u>(i)</u>  the drug was prescribed to a patient in a nursing care facility, [<strike>a</strike>] licensed<br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;intermediate care facility for people with an intellectual disability, or state prison facility,<br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;county jail, or state hospital;<br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(b)</strike>] <u>(ii)</u>  the drug was stored under the supervision of a licensed health care provider<br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;according to manufacturer recommendations;<br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(c)</strike>] <u>(iii)</u>  the drug is in a unit pack or in the manufacturer's sealed container;<br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(d)</strike>] <u>(iv)</u>  the drug was returned to the original dispensing pharmacy;<br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(e)</strike>] <u>(v)</u>  the drug was initially dispensed by a licensed pharmacist or licensed pharmacy<br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;intern; and<br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(f)</strike>] <u>(vi)</u>  accepting back and [<strike>redistribution</strike>] <u>redistributing</u> of the drug complies with<br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;federal Food and Drug Administration and Drug Enforcement Administration regulations.<br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>58-17b-901</b><a name="58-17b-901"></a> is enacted to read:<br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>Part 9.  Charitable Prescription Drug Recycling Act</b></center><br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-901.</u></b>  <b>Title.</b><br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This part is known as the "Charitable Prescription Drug Recycling Act."</u><br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.  Section <b>58-17b-902</b><a name="58-17b-902"></a> is enacted to read:<br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-902.</u></b>  <b>Definitions.</b><br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>As used in this part:</u><br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  "Assisted living facility" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-21-2&session=2016GS">26-21-2</a>.</u><br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Cancer drug" means a drug that controls or kills neoplastic cells and includes a</u><br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>drug used in chemotherapy to destroy cancer cells.</u><br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  "Charitable clinic" means a charitable nonprofit corporation that:</u><br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  holds a valid exemption from federal income taxation issued under Section 501(a),</u><br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Internal Revenue Code;</u><br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  is exempt from federal income taxation under Section 501(c)(3), Internal Revenue</u><br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Code;</u><br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  provides, on an outpatient basis, for a period of less than 24 consecutive hours, to</u><br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>an individual not residing or confined at a facility owned or operated by the charitable</u><br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>nonprofit corporation:</u><br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  advice;</u><br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  counseling;</u><br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  diagnosis;</u><br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  treatment;</u><br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  surgery; or</u><br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vi)  care or services relating to the preservation or maintenance of health; and</u><br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  has a licensed outpatient pharmacy.</u><br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  "Charitable pharmacy" means an eligible pharmacy that is operated by a charitable</u><br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>clinic.</u><br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  "County health department" means the same as that term is defined in Section</u><br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26a-1-102&session=2016GS">26A-1-102</a>.</u><br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(6)  "Donated prescription drug" means a prescription drug that an eligible donor</u><br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>donates to an eligible pharmacy under the program.</u><br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(7)  "Eligible donor" means a donor that donates a prescription drug from within the</u><br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>state and is:</u><br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  a nursing care facility;</u><br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  an assisted living facility;</u><br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  a licensed intermediate care facility for people with an intellectual disability;</u><br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  a manufacturer;</u><br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  a pharmaceutical wholesale distributor;</u><br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(f)  an eligible pharmacy; or</u><br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(g)  a physician's office.</u><br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(8)  "Eligible pharmacy" means a pharmacy that:</u><br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  is registered by the division as eligible to participate in the program; and</u><br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  is operated by:</u><br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  a county;</u><br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  a county health department;</u><br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  a pharmacy under contract with a county health department;</u><br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  the Department of Health, created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-1-4&session=2016GS">26-1-4</a>;</u><br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  the Division of Substance Abuse and Mental Health, created in Section</u><br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=62a-15-103&session=2016GS">62A-15-103</a>; or</u><br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vi)  a charitable clinic.</u><br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(9)  "Eligible prescription drug" means a prescription drug, described in Section</u><br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="#58-17b-904">58-17b-904</a>, that is not a controlled substance.</u><br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(10)  "Licensed intermediate care facility for people with an intellectual disability"</u><br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>means the same as that term is defined in Section <a href="#58-17b-503">58-17b-503</a>.</u><br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(11)  "Medically indigent individual" means an individual who:</u><br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  is eligible to receive Medicaid or Medicare; or</u><br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  does not have health insurance and lacks reasonable means to purchase prescribed</u><br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>medications.</u><br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(12)  "Nursing care facility" means the same as that term is defined in Section</u><br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-18-501&session=2016GS">26-18-501</a>.</u><br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(13)  "Physician's office" means a fixed medical facility that:</u><br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  is staffed by a physician, physician's assistant, nurse practitioner, or registered</u><br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>nurse, licensed under Title 58, Occupations and Professions; and</u><br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  treats an individual who presents at, or is transported to, the facility.</u><br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(14)  "Program" means the Charitable Prescription Drug Recycling Program created in</u><br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#58-17b-903">58-17b-903</a>.</u><br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(15)  "Unit pack" means the same as that term is defined in Section <a href="#58-17b-503">58-17b-503</a>.</u><br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(16)  "Unlawful conduct" means the same as that term is defined in Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2016GS">58-1-501</a></u><br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-501&session=2016GS">58-17b-501</a>.</u><br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(17)  "Unprofessional conduct" means the same as that term is defined in Sections</u><br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2016GS">58-1-501</a> and <a href="#58-17b-502">58-17b-502</a>.</u><br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  Section <b>58-17b-903</b><a name="58-17b-903"></a> is enacted to read:<br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-903.</u></b>  <b>Charitable Prescription Drug Recycling Program -- Creation --</b><br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Requirements.</b><br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  There is created the Charitable Prescription Drug Recycling Program.</u><br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  The division, in consultation with the board, shall:</u><br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  implement the program, on a statewide basis, to permit an eligible donor to transfer</u><br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>an eligible prescription drug to an eligible pharmacy for dispensing to a medically indigent</u><br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual;</u><br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act,</u><br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>make rules necessary to implement the program; and</u><br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  provide technical assistance to entities that desire to participate in the program.</u><br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.  Section <b>58-17b-904</b><a name="58-17b-904"></a> is enacted to read:<br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-904.</u></b>  <b>Criteria for eligible prescription drugs.</b><br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>An eligible pharmacy may not accept or dispense an unused prescription drug under the</u><br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>program unless the unused prescription drug:</u><br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1) (a)  is in the original sealed unit pack; or</u><br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  is an injectable medication;</u><br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2) (a)  is unopened; or</u><br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  is a cancer drug packaged in an unopened single-unit dose that has been removed</u><br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>from a multi-dose package;</u><br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  is accepted and dispensed by the eligible pharmacy before:</u><br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  a beyond use date that appears on the label;</u><br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the expiration date recommended by the manufacturer; or</u><br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  a date, established by division rule for a specific prescription drug, in accordance</u><br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date in</u><br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsection (3)(a) or (3)(b);</u><br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4) (a)  is not adulterated or mislabeled; and</u><br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the pharmacist or licensed pharmacist technician accepting or dispensing the</u><br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>prescription drug does not have reason to believe that the prescription drug is adulterated or</u><br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>mislabeled.</u><br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.  Section <b>58-17b-905</b><a name="58-17b-905"></a> is enacted to read:<br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-905.</u></b>  <b>Participation in program -- Requirements -- Fees.</b><br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  An eligible donor or an eligible pharmacy may participate in the program.</u><br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  An eligible pharmacy:</u><br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  shall comply with all applicable federal and state laws related to the storage and</u><br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>distribution of a prescription drug;</u><br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  shall comply with all applicable federal and state laws related to the acceptance and</u><br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>transfer of a prescription drug, including 21 U.S.C. Chapter 9, Subchapter V, Part H,</u><br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Pharmaceutical Distribution Supply Chain;</u><br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  shall, before accepting or dispensing a prescription drug under the program, inspect</u><br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>each prescription drug to determine whether the prescription drug is an eligible prescription</u><br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>drug;</u><br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  may dispense an eligible prescription drug to a medically indigent individual who:</u><br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  is a resident of the state; and</u><br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  has a prescription issued by a practitioner;</u><br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  may charge a handling fee, adopted by the division under Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63j-1-504&session=2016GS">63J-1-504</a>; and</u><br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(f)  may not accept, transfer, or dispense a prescription drug in violation of the federal</u><br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Food, Drug, and Cosmetic Act, 21 U.S.C. Sec. 301 et seq.</u><br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.  Section <b>58-17b-906</b><a name="58-17b-906"></a> is enacted to read:<br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-906.</u></b>  <b>Liability of participating organizations and manufacturers.</b><br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>A person is not liable for injury, death, or loss of property based solely on the fact that</u><br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the person donated, accepted, or dispensed an eligible prescription drug under this part.</u><br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.  Section <b>58-17b-907</b><a name="58-17b-907"></a> is enacted to read:<br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-17b-907.</u></b>  <b>Rules made by the division.</b><br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>The rules made by the division under Subsection <a href="#58-17b-903">58-17b-903</a>(2)(b) shall include:</u><br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  registration requirements to establish the eligibility of a pharmacy to participate in</u><br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the program;</u><br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  a formulary that includes all eligible prescription drugs approved by the federal</u><br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Food and Drug Administration;</u><br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  standards and procedures for:</u><br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  verifying whether a pharmacy or pharmacist participating in the program is licensed</u><br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and in good standing with the board;</u><br/>251&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  handling of a donated eligible prescription drug, including:</u><br/>252&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  acceptance;</u><br/>253&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  identification, including redundant criteria for verification;</u><br/>254&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history,</u><br/>255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and statements;</u><br/>256&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  safe storage;</u><br/>257&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  security;</u><br/>258&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vi)  inspection;</u><br/>259&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vii)  transfer; and</u><br/>260&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(viii)  dispensing;</u><br/>261&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  a pharmacist or licensed pharmacy technician working in or consulting with a</u><br/>262&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>participating eligible donor;</u><br/>263&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  disposition of a donated prescription drug that is a controlled substance;</u><br/>264&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  record keeping regarding:</u><br/>265&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the eligible donor that donated each prescription drug;</u><br/>266&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  the identification and evaluation of a donated prescription drug by a pharmacist or</u><br/>267&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>licensed pharmacy technician; and</u><br/>268&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  the dispensing or disposition of a prescription drug;</u><br/>269&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(f)  determining the status of a medically indigent individual;</u><br/>270&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(g)  labeling requirements to:</u><br/>271&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  ensure compliance with patient privacy laws relating to:</u><br/>272&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(A)  an individual who receives an eligible prescription drug; and</u><br/>273&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(B)  patient information that may appear on a donated prescription drug;</u><br/>274&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  clearly identify an eligible prescription drug dispensed under the program; and</u><br/>275&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  communicate necessary information regarding the manufacturer's recommended</u><br/><hr>276&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>expiration date or the beyond use date; and</u><br/>277&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(h)  ensuring compliance with the requirements of this part;</u><br/>278&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  a process for seeking input from:</u><br/>279&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  the Department of Health, created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-1-4&session=2016GS">26-1-4</a>, to establish program standards</u><br/>280&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and procedures for assisted living facilities and nursing care facilities; and</u><br/>281&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the Division of Substance Abuse and Mental Health, created in Section</u><br/>282&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=62a-15-103&session=2016GS">62A-15-103</a>, to establish program standards and procedures for mental health and substance</u><br/>283&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>abuse clients; and</u><br/>284&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  the creation of a special training program that a pharmacist and a licensed pharmacy</u><br/>285&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>technician at an eligible pharmacy must complete before participating in the program.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
